Design And Development Of Gemcitabine Nanoemulsion For Pulmonary Delivery
|
|
Author:
|
MERRYL D’SILVA, AFRASIM MOIN, RACHNA.M .KUMAR, SIDDARAMAIAH, D.V. GOWDA
|
Abstract:
|
Objective: Gemcitabine a synthetic pyrimidine nucleoside prodrug with antineoplastic activity. In this study Gemcitabine (GM) nanoemulsion (NE) was developed and evaluated for pulmonary delivery.
Method : GM loaded NE was prepared with cremophor RH 40 (oil), PEG 400(co-surfactant) and labrafil M2125Cs(surfactant )in a ratio of 2:1:1. The formulations were evaluated for particle size, zeta potential, pH, in-vitro drug release, rheology studies, and conductivity.
Result: The particle size of the blank and drug-loaded NE was found to be 22 nm. The pH of the prepared formulations was well within the limit (6.35 ± 0.02 to 7.01 ± 0.002). The optimized formulation was sterilized by aseptic filtration. From the polarized light microscopy study, the isotopic nature of optimized NE formulation was confirmed. The drug entrapment efficiency and the in-vitro drug release was found to be 89% and 93% respectively. The optimized formulation M2 was found to be stable from the stability studies.
Conclusion: The optimized formulation M2 was found to be stable and can be potentially used in pulmonary delivery.
|
Keyword:
|
Gemcitabine, Nano emulsion, Pulmonary drug delivery
|
EOI:
|
-
|
DOI:
|
https://doi.org/10.31838/ijpr/2021.13.01.563
|
Download:
|
Request For Article
|
|
|